NCT00037557View on ClinicalTrials.gov

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

November 30, 2007

Conditions
Hemophilia B
Interventions
DRUG

BeneFIX

Trial Locations (6)

45404

Dayton

48201

Detroit

77030

Houston

80262

Aurora

08903

New Brunswick

27599-7220

Chapel Hill

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00037557 - Study Evaluating rFIX; BeneFIX in Severe Hemophilia B | Biotech Hunter | Biotech Hunter